Thomas Tuschl

E849217

Thomas Tuschl is a German biochemist and pioneering RNA interference researcher whose work helped lay the scientific foundation for RNA-based therapeutics.

Try in SPARQL Jump to: Surface forms Statements Referenced by

All labels observed (1)

Label Occurrences
Thomas Tuschl canonical 1

Statements (45)

Predicate Object
instanceOf RNA interference researcher
biochemist
human
university teacher
awardReceived Ernst Jung Prize for Medicine NERFINISHED
Louis-Jeantet Prize for Medicine NERFINISHED
Massry Prize NERFINISHED
Meyenburg Cancer Research Award NERFINISHED
Meyenburg Prize NERFINISHED
countryOfCitizenship Germany
educatedAt Max Planck Institute for Experimental Medicine NERFINISHED
University of Regensburg NERFINISHED
employer Rockefeller University NERFINISHED
familyName Tuschl NERFINISHED
fieldOfWork RNA biology
RNA interference NERFINISHED
RNA therapeutics
biochemistry
gene silencing
molecular biology
givenName Thomas NERFINISHED
hasAcademicAdvisor Ernst-Ludwig Winnacker NERFINISHED
Fritz Eckstein NERFINISHED
hasResearchInterest RNA processing
microRNAs
post-transcriptional gene regulation
small interfering RNAs
influenced development of RNAi-based drugs
influencedBy Andrew Fire NERFINISHED
Craig Mello NERFINISHED
knownFor demonstrating that synthetic siRNAs can induce RNAi in mammalian cells
design rules for effective siRNAs
patents on RNA interference technologies
languageSpoken English
German
memberOf Howard Hughes Medical Institute NERFINISHED
Max Planck Society (as researcher/alumnus) NERFINISHED
name Thomas Tuschl NERFINISHED
nationality German
notableFor contributions to RNA-based therapeutics
development of small interfering RNA (siRNA) technology
pioneering work on RNA interference in mammalian cells
positionHeld professor at Rockefeller University
sexOrGender male
workLocation New York City

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Alnylam Pharmaceuticals foundedBy Thomas Tuschl